Affiliation:
1. Clinic of Dermatovenereology, Clinical Center of Vojvodina , Novi Sad
2. Faculty of Medicine Novi Sad , University of Novi Sad
3. Institute for Oncology of Vojvodina , Sremska Kamenica
Abstract
Abstract
Radiation dermatitis is one of the commonest side effects of ionizing radiation which is applied in radiotherapy of carcinoma of all localizations, most frequently of tumors of breast, head and neck region, lungs and soft tissue sarcomas. It usually occurs as a complication of breast radiotherapy and thus it is more often recorded in female patients on the skin in the region of breast subjected to radiation. Clinical manifestations of radiation dermatitis can be divided into four phases: acute phase (erythema, dry desquamation, moist desquamation, ulceration and necrosis with resulting re-epithelialization, residual post-inflammatory hyperpigmentation, reduction and suppression of sebaceous and sweat glands and epilation); subacute phase (hyperpigmentation and hypopigmentation, telangiectasia, skin atrophy, even ulceration); chronic phase (skin atrophy, dermal fibrosis and permanent skin epilation) and late phase (increased risk of skin cancer). In order to prevent radiation dermatitis, skin care products should be applied throughout radiotherapy that will decrease the frequency of skin reactions or block them and thus improve life quality. Although the therapy includes not only topical corticosteroids but numerous other products with active ingredients such as aloe vera, calendula, hyaluronic acid, sucralfat, sorbolene, mineral and olive oil, honey, vitamin C, zinc, antimicrobials and silver, common therapeutic consensus has not been reached on their application in radiation dermatitis. Therefore, the treatment should be conducted according to the basic guidelines but tailor-made for each individual patient.
Reference72 articles.
1. 1. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 2008;19(1):142-9.10.1093/annonc/mdm400
2. 2. Spalek M. Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:473-82.10.2147/CCID.S94320
3. 3. Đurović B. Radijacione povrede kože. U: Karadaglić Đ, editor. Dermatologija. Beograd: Karadaglić Đ; 2016. p. 1486-500.
4. 4. Kumar S. Second malignant neoplasms following radiotherapy. Int J Environ Res Public Health. 2012;9(12):4744-59.10.3390/ijerph9124744
5. 5. Spasić B, Tešanović D, Ivanov O. Skin toxicity associated with Cetuximab treatment during radiotherapy of head and neck cancer. In: Abstracts of the 20th Congress of the Serbian Association of Dermatovenerologists; 2017 May 18-20; Belgrade, Serbia. Serbian Journal of Dermatology and Venereology. 2017;9(2):92.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献